posted on 2021-04-13, 03:36authored byPin Zhang, Binghe Xu, Lin Gui, Wenna Wang, Meng Xiu, Xiao Zhang, Guilan Sun, Xiaoyu Zhu, Jianjun Zou
Additional file 1: Online supplemental figures and tables.docx. Figure S1. Linear plot of concentration-time profile for dalpiciclib by dose. Table S1. Dose modifications after DLT assessment period. Table S2. Treatment emergent AEs occurring in ≥2 patients and AEs of special interest. Table S3. Pharmacokinetics and pharmacological characteristics of CDK4/6 inhibitors.